These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3181817)

  • 1. Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during L-asparaginase treatment in leukemic children.
    Legnani C; Palareti G; Pession A; Poggi M; Vecchi V; Bianchini B; Coccheri S
    Haemostasis; 1988; 18(3):179-86. PubMed ID: 3181817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
    Mazzucconi MG; Gugliotta L; Leone G; Dragoni F; Belmonte MM; De Stefano V; Chistolini A; Tura S; Mandelli F
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):23-8. PubMed ID: 7514043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy.
    Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Ito K; Matsuda T
    Am J Hematol; 1989 Sep; 32(1):20-3. PubMed ID: 2757000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.
    Zaunschirm A; Muntean W
    Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
    Rodeghiero F; Castaman G; Dini E
    Thromb Res; 1990 Jan; 57(1):31-8. PubMed ID: 2300923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study.
    Risseeuw-Appel IM; Dekker I; Hop WC; Hählen K
    Med Pediatr Oncol; 1994; 23(4):335-43. PubMed ID: 8058004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in blood coagulation in treatment with ALL-BFM-90 and NHL-BFM-90 protocols].
    Sutor AH; Niemeyer C; Sauter S; Witt I; Kaufmehl K; Rombach A; Brandis M; Riehm H
    Klin Padiatr; 1992; 204(4):264-73. PubMed ID: 1518263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation.
    Nowak-Göttl U; Ahlke E; Schulze-Westhoff P; Boos J
    Br J Haematol; 1996 Oct; 95(1):123-6. PubMed ID: 8857948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
    Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
    Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
    Merlen C; Bonnefoy A; Wagner E; Dedeken L; Leclerc JM; Laverdière C; Rivard GE
    Pediatr Blood Cancer; 2015 Aug; 62(8):1381-7. PubMed ID: 25820776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
    Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
    J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
    Beinart G; Damon L
    Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathic side effect of L-asparaginase on fibrinogen level in childhood acute lymphoblastic leukemia during induction phase.
    Alqasim AMZ; Al-Hadithi RH; Al-Khalidi AN
    Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):67-69. PubMed ID: 29406239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin and fibrinogen levels as predictors for plasma L-asparaginase activity in children with acute lymphoblastic leukemia.
    Merlen C; Bonnefoy A; Afeich C; Théorêt Y; Laverdière C; Leclerc JM; Rivard GE
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27729. PubMed ID: 30938058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
    Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Söderhäll S; Petrini P; Mäkipernaa AM
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):749-56. PubMed ID: 24056293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis in children receiving L-asparaginase. Determining patients at risk.
    Shapiro AD; Clarke SL; Christian JM; Odom LF; Hathaway WE
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):400-5. PubMed ID: 8214362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.